CoChat

Pharmacodynamics of romiplostim alone and in combination with pegfilgrastim on acute radiation-induced thrombocytopenia and neutropenia in non-human primates

The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.

Abstract

Purpose: Evaluation of the pharmacodynamics (PD) and pharmacokinetics (PK) of romiplostim alone and in combination with pegfilgrastim in a non-human primate (NHP) model of acute radiation syndrome (ARS).Materials and methods: Male and female rhesus macaques were subjected to Cobalt-60 γ irradiation, at a dose of 550 cGy 24 h prior to subcutaneous administration of either romiplostim alone as a single (2.5 or 5.0 mg/kg on Day 1) or repeat dose (5.0 mg/kg on Days 1 and 8), pegfilgrastim alone as a repeat dose (0.3 µg/kg on Day 1 and 8), or a combination of both agents (romiplostim 5.0 mg/kg on Day 1; pegfilgrastim 0.3 µg/kg on Days 1 and 8). Clinical outcome, hematological parameters and PK were assessed throughout the 45 d study period post-irradiation.Results: Administration of romiplostim, pegfilgrastim or the combination of both resulted in significant improvements in hematological parameters, notably prevention of severe thrombocytopenia, compared with irradiated, vehicle control-treated NHPs. The largest hematologic benefit was observed when romiplostim and pegfilgrastim were administered as a combination therapy with much greater effects on both platelet and neutrophil recovery following irradiation compared to single agents alone.Conclusions: These results indicate that romiplostim alone or in combination with pegfilgrastim is effective at improving hematological parameters in an NHP model of ARS. This study supports further study of romiplostim as a medical countermeasure to improve primary hemostasis and survival in ARS.

Overview

Integrity signals

Registry

Crossref · 10.1080/09553002.2019.1625488

Cites

34 of 34 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 34 references

Research works printed but not linked: 5

  1. Neelis KJ, 1997, Exp Hematol, 25, 1084
  2. NEULASTA®., 2018, (Pegfilgrastrim) [product monograph]
  3. NEUPOGEN®., 2018, (Filgrastim) [product monograph]
  4. NPLATE®., 2018, (Romiplostim) [product monograph]
  5. Wendling F, 1996, Ann Pharm Fr, 54, 177

Cited by

See all 57

Metadata

Authors
Wong, K., Chang, P. Y., Fielden, M., Downey, A. M., Bunin, D., Bakke, J., Gahagen, J., Iyer, L., Doshi, S., Wierzbicki, W., & Authier, S.
Affiliations
  • Citoxlab North America, Laval, Quebec, Canada;
  • SRI International (US)
  • Amgen (United States) (US)
  • Université de Montréal (CA)
Corresponding author
Authier, Simon
Venue
International Journal of Radiation Biology
Published
2019-06-21
Volume
96
Issue
1
Pages
155-166
ISSN
  • 0955-3002 (ISSN-L)
  • 1362-3095
OpenAlex
W2949172829
Cited by
57
References
34
Citations by year
2026: 7 · 2025: 10 · 2024: 10 · 2023: 8 · 2022: 8 · 2021: 7 · 2020: 5 · 2019: 1
FWCI
3.46
Type
journal article
Language
en
Open access
closed
Locations
  • International Journal of Radiation Biology (publishedVersion)
  • PubMed (publishedVersion)
Funders
National Institute of Allergy and Infectious Diseases within the National Institutes of Health
Topics
  • Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Effects of Radiation Exposure
  • Health Sciences › Medicine › Hematology › Platelet Disorders and Treatments
  • Health Sciences › Medicine › Oncology › Neutropenia and Cancer Infections
Keywords
romiplostim, pegfilgrastim, radiation sickness, radiation-induced thrombocytopenia, combination therapy, hematopoietic recovery, platelet recovery, nonhuman primate model, cobalt-60 gamma irradiation, medical countermeasures, pharmacodynamics, pharmacokinetics
MeSH terms
Filgrastim, Animals, Blood Coagulation, Dose-Response Relationship, Drug, Drug Interactions, Female, Macaca mulatta, Male, Neutropenia, Polyethylene Glycols, Radiation Injuries, Experimental, Receptors, Fc, Recombinant Fusion Proteins, Thrombocytopenia, Thrombopoietin, Time Factors

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Pharmacodynamics of romiplostim alone and in combination with pegfilgrastim on acute radiation-induced thrombocytopenia and neutropenia in non-human primates. https://app.cochat.ai/papers/10.1080/09553002.2019.1625488
The paper
Wong, K., Chang, P. Y., Fielden, M., Downey, A. M., Bunin, D., Bakke, J., Gahagen, J., Iyer, L., Doshi, S., Wierzbicki, W., & Authier, S. (2020). Pharmacodynamics of romiplostim alone and in combination with pegfilgrastim on acute radiation-induced thrombocytopenia and neutropenia in non-human primates. International Journal of Radiation Biology. https://doi.org/10.1080/09553002.2019.1625488

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.